tiprankstipranks
Genenta Science CEO to present at U.S. Senate meeting
PremiumThe FlyGenenta Science CEO to present at U.S. Senate meeting
4M ago
Genenta Science SPA (ADR) trading resumes
Premium
The Fly
Genenta Science SPA (ADR) trading resumes
4M ago
Genenta Science SPA (ADR) trading resumes
Premium
The Fly
Genenta Science SPA (ADR) trading resumes
5M ago
Genenta Science Announces Board Restructuring
PremiumCompany AnnouncementsGenenta Science Announces Board Restructuring
11M ago
Genenta Science Announces Shareholder Meeting
Premium
Company Announcements
Genenta Science Announces Shareholder Meeting
11M ago
Genenta Science’s Loyalty Shares: A Double-Edged Sword for ADS Liquidity and Investor Influence?
Premium
Company Announcements
Genenta Science’s Loyalty Shares: A Double-Edged Sword for ADS Liquidity and Investor Influence?
11M ago
Genenta Science receives Orphan Drug Designation from EC for Temferon
PremiumThe FlyGenenta Science receives Orphan Drug Designation from EC for Temferon
2y ago
Genenta Science sees cash sufficient to continue operations into 1Q25
Premium
The Fly
Genenta Science sees cash sufficient to continue operations into 1Q25
2y ago
Genenta Science reports 2022 net loss EUR 8.5M vs. EUR 5.5M last year
Premium
The Fly
Genenta Science reports 2022 net loss EUR 8.5M vs. EUR 5.5M last year
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100